Business
WELL Health Provides Business Update Reflecting Strong Growth in Patient Visits and Enhanced Revenue Outlook for Q4-2021
WELL Health Provides Business Update Reflecting Strong Growth in Patient Visits and Enhan...
About this update from Well Health Technologies Corp.
[{"type":"text","content":"\n \n \n \n WELL Health Provides Business Update Reflecting Strong Growth in Patient Visits and Enhanced Revenue Outlook for Q4-2021\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n WELL expects to announce strong, record financial performance for Q4-2021 with annualized revenue run-rate exceeding\n \n C$450 million\n \n , which is better than the previously provided guidance. WELL also expects to achieve annualized operating Adjusted EBITDA run-rate approaching\n \n C$100 million\n \n in Q4-2021.\n \n \n Total omni-channel patient visits\n \n (1)\n \n in Q4-2021 increased by 121% to 692,913 compared to Q4-2020, and reflected a 19% increase as compared to Q3-2021.\n \n \n CRH Medical (\"\n \n CRH\n \n \"), had a solid Q4-2021 and continues to execute to plan. The company is on track to deliver approximately\n \n US$43 million\n \n in free cashflow before tax and leverage costs for the full year in 2021.\n \n \n WELL expects strong growth from its US focused virtual services businesses in Q4-2021, with Circle Medical and Wisp revenues approaching\n \n US$70 million\n \n in annualized revenue run-rate on a combined basis. Circle Medical and Wisp's combined revenue run-rate is expected to exceed\n \n US$100M\n \n later in 2022.\n \n \n WELL plans to activate its previously approved share buyback program after it has released its Q4 and 2021 financial results and is no longer restricted.\n \n \n \n \n \n VANCOUVER, BC\n \n \n ,\n \n \n Jan. 20, 2022\n \n \n /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (\"\n \n WELL\n \n \" or the \"\n \n Company\n \n \"), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce preliminary results for Q4-2021 ending\n \n December 31, 2021\n \n are expected to demonstrate strong financial performance underpinned by significant growth in patient visits. The Company ended Q4 and 2021 with an annualized revenue run-rate exceeding\n \n C$450 million\n \n and annualized operating Adjust...